Researchers have figured out a way to switch the immunosuppressive phenotype of tumor-associated macrophages to one that's immunostimulatory. By inhibiting PI3K in these macrophages, they significantly suppressed tumor growth in mice; when anti–PD-1 therapy was added to PI3K inhibition, complete and sustained tumor eradication was observed in many cases.
http://ift.tt/2gX2ZY6
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου